e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Management of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Latent tuberculosis infection (LTBI) treatment completion and complication in Leeds, UK
R. Ahmed, M. Arif, D. Hopper, C. Mullarkey, S. Moffitt, J. Watson (Leeds, United Kingdom)
Source:
Annual Congress 2011 - Management of tuberculosis
Session:
Management of tuberculosis
Session type:
Thematic Poster Session
Number:
2608
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Ahmed, M. Arif, D. Hopper, C. Mullarkey, S. Moffitt, J. Watson (Leeds, United Kingdom). Latent tuberculosis infection (LTBI) treatment completion and complication in Leeds, UK. Eur Respir J 2011; 38: Suppl. 55, 2608
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Occupational and drug-induced ILDs
PG16 Advanced cardiopulmonary exercise testing
Related content which might interest you:
High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
An audit of diagnosis and chemoprophylaxis treatment of latent tuberculosis Infection (LTBI) in TB contact patients in a district general hospital (DGH) in the United Kingdom (UK)
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
Monitoring latent tuberculosis infection diagnosis and management in the Netherlands
Source: Eur Respir J 2016; 47:1492-1501
Year: 2016
Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Acceptance, and compliance to treatment for latent tuberculous infection (LTBI) in Geneva (1993-2002)
Source: Eur Respir J 2005; 26: Suppl. 49, 645s
Year: 2005
Latent tuberculous infection (LTBI) in employees of Geneva University Hospital: estimation of annual risk of infection over a 5-year period
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Risk of developing active TB in children with latent TB infection
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Screening for tuberculosis in patients with COVID-19 infection in Georgia.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection
Source: International Congress 2017 – Migrants and screening
Year: 2017
Recurrence of tuberculosis in a low-incidence setting
Source: Eur Respir J 2009; 33: 160-167
Year: 2009
Diagnostics of the latent TBC infection (LTBI) activity in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel
Source: Eur Respir J 2008; 32: 413-418
Year: 2008
New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Tuberculosis (TB) detection with HIV infected patients
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Treatment of latent infection with Mycobacterium tuberculosis: update 2010
Source: Eur Respir J 2011; 37: 690-711
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept